InChI=1S/C28H44O2/c1-19-10-14-24(29)18-23(19)13-12-22-8-7-17-28(6)25(15-16-26(22)28)20(2)9-11-21(3)27(4,5)30/h9,11-13,20-21,24-26,29-30H,1,7-8,10,14-18H2,2-6H3/b11-9+,22-12+,23-13-/t20-,21+,24+,25-,26+,28-/m1/s1 |
KJKIIUAXZGLUND-ICCVIKJNSA-N |
C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C |
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
fat-soluble vitamin (role)
Any vitamin that dissolves in fats and are stored in body tissues. Unlike the water-soluble vitamins, they are stored in the body for long periods of time and generally pose a greater risk for toxicity when consumed in excess.
(via vitamin D )
|
|
bone density conservation agent
An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis.
nutraceutical
A product in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.
|
|
View more via ChEBI Ontology
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-3,25-diol
|
25-Hydroxycalciferol
|
HMDB
|
25-hydroxyergocalciferol
|
LIPID MAPS
|
25-hydroxyvitamin D2
|
UniProt
|
9,10-secoergosta-5,7,10(19),22-tetraene-3β,25-diol
|
HMDB
|
ercalcidiol
|
HMDB
|
21343-40-8
|
CAS Registry Number
|
ChemIDplus
|
4716773
|
Reaxys Registry Number
|
Reaxys
|
15465040
|
PubMed citation
|
SUBMITTER
|
25125396
|
PubMed citation
|
Europe PMC
|
25211403
|
PubMed citation
|
Europe PMC
|
25403087
|
PubMed citation
|
Europe PMC
|
25575651
|
PubMed citation
|
Europe PMC
|
25587834
|
PubMed citation
|
Europe PMC
|
25729734
|
PubMed citation
|
Europe PMC
|
25845705
|
PubMed citation
|
Europe PMC
|
25967149
|
PubMed citation
|
Europe PMC
|
26025465
|
PubMed citation
|
Europe PMC
|
26054580
|
PubMed citation
|
Europe PMC
|
26059899
|
PubMed citation
|
Europe PMC
|
|